공지
- [ 2024-05-30 ] 2024년 제1차 사전연명의료의향서 등록기관 지정 결과 공고
- [ 2024-05-22 ] 2024년 한국생명윤리학회 춘계공동학술대회 개최 안내(6/28(금))
- [ 2024-05-22 ] 2024년 대한의료커뮤니케이션학회 춘계학술대회 개최 안내(6/8(토))
- [ 2024-05-10 ] 공용위원회 심의·협약 대상 및 비용 납부 안내 규정 공고
- [ 2024-05-07 ] 2024년 한국의료윤리학회 춘계학술대회 개최 안내(5/25(토))
관련 논문
*정책원 미소장 자료이며 관련 논문 소개 게시판입니다. 게시물 관련링크를 눌러 소속기관에서 열람가능한지 확인해주시기 바랍니다.
lib@nibp.kr
글 수 4,668
| 발행년 : | 2018 |
|---|---|
| 구분 : | 국내학술지 |
| 학술지명 : | 보건행정학회지 |
| 관련링크 : | http://www.riss.kr/link?id=A105625865 |
우리나라 보건의료 발전을 위한 의료기술평가의 역할
= Roles of Health Technology Assessment for Better Health and Universal Health Coverage in Korea
- 저자[authors] 이영성 ( Young Sung Lee )
- 학술지명[periodical name] 보건행정학회지
- 권호사항[Volume/Issue] Vol.28No.3[2018]
- 발행처[publisher] 한국보건행정학회
- 자료유형[Document Type] 학술저널
- 수록면[Pagination] 263-271
- 언어[language] Korean
- 발행년[Publication Year] 2018
- 주제어[descriptor] Health technology assessment, Health technology reassessment, National Evidence-based Healthcare Collaborating Agency, Evidence-based healthcare policy, Big data & health technology assessment platform, Value-based health technology as-sessment
초록[abstracts]
[Health technology assessment (HTA) is defined as multidisciplinary policy analysis to look into the medical, economic, social, and ethical implications of the development, distribution, and use of health technology. Following the recent changes in the social environment, there are increasing needs to improve Korea’s healthcare environment by, inter alia, assessing health technologies in an organized, timely manner in accordance with the government’s strategies to ensure that citizens’ medical expenses are kept at a stable level. Dedicated to HTA and research, the National Evidence-based Healthcare Collaborating Agency (NECA) analyzes and provides grounds on the clinical safety, efficacy, and economic feasibility of health technologies. HTA offers the most suitable grounds for decision making not only by healthcare professionals but also by policy makers and citizens as seen in a case in 2009 where research revealed that glucosamine lacked preventive and treatment effects for osteoarthritis and glucosamine was subsequently excluded from the National Health Insurance’s benefit list to stop the insurance scheme from suffering financial losses and citizens from paying unnecessary medical expenses. For the development of HTA in Korea, the NECA will continue exerting itself to accomplish its mission of providing policy support by health technology reassessment, promoting the establishment and use of big data and HTA platforms for public interest, and developing a new value-based HTA system.]
(†04522) 서울 특별시 중구 남대문로 113 DB다동빌딩 5층
TEL : 02-737-8970 (기획운영팀)
Copyright (c)KONIBP All Right Reserved.
Copyright (c)KONIBP All Right Reserved.
2sisstore
